(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are THUNDERBIRD, TRIGANO, and TOYOTA CAETANO.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| THUNDERBIRD (TBIRD.AS) | 0.07 | 12.1% | 2023-05-18 11:04:35 |
| TRIGANO (TRI.PA) | 129.40 | 11.94% | 2023-05-18 11:04:34 |
| TOYOTA CAETANO (SCT.LS) | 4.54 | 10.73% | 2023-05-18 11:19:37 |
| ESI GROUP (ESI.PA) | 99.40 | 10.44% | 2023-05-18 11:48:05 |
| BPOST (BPOST.BR) | 4.02 | 6.29% | 2023-05-18 08:05:47 |
| PCAS (PCA.PA) | 7.00 | 6.06% | 2023-05-18 11:01:26 |
| FONCIERE EURIS (EURS.PA) | 2.00 | 5.26% | 2023-05-18 08:49:10 |
| CRCAM ATL.VEND.CCI (CRAV.PA) | 87.48 | 4.77% | 2023-05-18 11:46:46 |
| INVENTIVA (IVA.PA) | 2.32 | 4.74% | 2023-05-18 11:50:53 |
| GALAPAGOS (GLPG.AS) | 39.68 | 4.26% | 2023-05-18 11:02:25 |
The three biggest losers today are NEW SOURCES ENERGY, ATENOR, and CNOVA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| NEW SOURCES ENERGY (NSE.AS) | 0.03 | -18.99% | 2023-05-18 11:03:26 |
| ATENOR (ATEB.BR) | 31.50 | -15.09% | 2023-05-18 11:05:33 |
| CNOVA (CNV.PA) | 3.80 | -9.31% | 2023-05-18 11:46:27 |
| LAVIDE HOLDING (LVIDE.AS) | 0.22 | -9.24% | 2023-05-18 08:02:58 |
| FUT.CLUBE PORTO (FCP.LS) | 1.04 | -7.96% | 2023-05-18 11:18:42 |
| NANOBIOTIX (NANO.PA) | 4.53 | -6.51% | 2023-05-18 11:00:35 |
| NHOA (NHOA.PA) | 3.58 | -5.79% | 2023-05-18 11:00:49 |
| HYLORIS (HYL.BR) | 11.40 | -4.2% | 2023-05-18 11:15:10 |
| BIOSENIC (BIOS.BR) | 0.12 | -4% | 2023-05-18 08:05:43 |
| ABIONYX PHARMA (ABNX.PA) | 1.78 | -3.78% | 2023-05-18 11:35:19 |
Winners today
1. THUNDERBIRD (TBIRD.AS)
12.1% Price Change
Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.
AEX-Index ended the session with THUNDERBIRD jumping 12.1% to €0.07 on Thursday, after three consecutive sessions in a row of losses. AEX-Index jumped 0.92% to €765.28, after five successive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.01.
PE Ratio
THUNDERBIRD has a trailing twelve months price to earnings ratio of 6.95. Meaning, the purchaser of the share is investing €6.95 for every euro of annual earnings.
Volume
Today’s last reported volume for THUNDERBIRD is 16500 which is 52.34% below its average volume of 34621.
More news about THUNDERBIRD.
2. TRIGANO (TRI.PA)
11.94% Price Change
Trigano S.A., together with its subsidiaries, engages in the design, manufacture, marketing, and sale of leisure vehicles for individuals and professionals in Europe. It offers camping cars, caravans, motorhomes, trailers, and outdoor habitats. The company also provides mobiles homes, spare parts, and accessories, as well as leisure financing services. It offers its products through dealer networks and distributors, as well as through its online sales site, Triganostore.com. Trigano S.A. was founded in 1935 and is based in Paris, France.
CAC 40 ended the session with TRIGANO jumping 11.94% to €129.40 on Thursday while CAC 40 jumped 0.64% to €7,446.89.
Earnings Per Share
As for profitability, TRIGANO has a trailing twelve months EPS of €14.45.
PE Ratio
TRIGANO has a trailing twelve months price to earnings ratio of 8.96. Meaning, the purchaser of the share is investing €8.96 for every euro of annual earnings.
More news about TRIGANO.
3. TOYOTA CAETANO (SCT.LS)
10.73% Price Change
Toyota Caetano Portugal, S.A. imports, assembles, and commercializes light and heavy vehicles. It offers commercial and passenger cars, as well as parts; cargo handling machines; and mini-buses. The company also sells and rents industrial equipment, including counterweight forklift trucks and warehouse equipment; provides technical after-sales assistance; incorporates components into commercial vehicles; and offers business services and solutions, such as short-term rental, used and reconditioned assistance, maintenance contracts sale of parts, and fleet management of related equipment. It distributes its products under the Toyota and Lexus brand names in Portugal, Belgium, African countries, Spain, Germany, the United Kingdom, and internationally. The company was incorporated in 1946 and is headquartered in Vila Nova de Gaia, Portugal. Toyota Caetano Portugal, S.A. is a subsidiary of Salvador Caetano Auto (S.G.P.S.), S.A.
PSI ended the session with TOYOTA CAETANO jumping 10.73% to €4.54 on Thursday while PSI fell 0.55% to €6,056.56.
Earnings Per Share
As for profitability, TOYOTA CAETANO has a trailing twelve months EPS of €0.39.
PE Ratio
TOYOTA CAETANO has a trailing twelve months price to earnings ratio of 11.64. Meaning, the purchaser of the share is investing €11.64 for every euro of annual earnings.
More news about TOYOTA CAETANO.
4. ESI GROUP (ESI.PA)
10.44% Price Change
ESI Group SA, together with its subsidiaries, designs, develops, and distributes virtual prototyping software solutions in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. The company offers vibro-acoustics, which allows engineers to perform accurate predictive noise and vibration design assessments early in the design cycle; virtual performance solutions; and virtual seat solutions. It also provides SimulationX, a single platform for modeling, simulating, and analyzing technical systems; SYSWELD, which enables the designers and process planners to virtually manufacture, assemble, and test physically realistic virtual assemblies; SYSTUS, which offers a complete resolution to analysis challenges in mechanics, heat transfer, and electrotechnics; PAM-STAMP that provides sheet metal forming solutions; interior solutions; PAM-COMPOSITES; IC.IDO, a virtual reality engineering software; and ProCAST, which offers casting solutions, such as die casting, sand casting, and investment casting. In addition, the company offers consulting, technical support and assistance, and training services. It serves aerospace, defense, naval, automotive and land transport, energy, ground transportation, heavy machinery industries. The company was founded in 1973 and is headquartered in Rungis, France.
CAC 40 ended the session with ESI GROUP jumping 10.44% to €99.40 on Thursday, after two consecutive sessions in a row of losses. CAC 40 rose 0.64% to €7,446.89, after two successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, ESI GROUP has a trailing twelve months EPS of €2.89.
PE Ratio
ESI GROUP has a trailing twelve months price to earnings ratio of 34.39. Meaning, the purchaser of the share is investing €34.39 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.98%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ESI GROUP’s stock is considered to be oversold (<=20).
Moving Average
ESI GROUP’s value is way above its 50-day moving average of €76.66 and way higher than its 200-day moving average of €73.21.
More news about ESI GROUP.
5. BPOST (BPOST.BR)
6.29% Price Change
bpost NV/SA, together with its subsidiaries, provides mail and parcel services to individuals, businesses, and public institutions in Belgium, rest of Europe, the United States, and internationally. It operates through Belgium, E-Logistics Eurasia, E-Logistics North America, and Corporate segments. The company offers collection, transport, sorting, and distribution of addressed and non-addressed mail, printed documents, newspapers, periodicals, and parcels, as well as banking and financial products, e-commerce logistics, express delivery, proximity and convenience, document management, and related services. It also provides transactional mails, advertising mails, press, domestic and international parcels, logistic solutions, and cross-border products, as well as value-added services. The company was incorporated in 1830 and is headquartered in Brussels, Belgium.
BEL 20 ended the session with BPOST rising 6.29% to €4.02 on Thursday while BEL 20 jumped 0.97% to €3,717.30.
Earnings Per Share
As for profitability, BPOST has a trailing twelve months EPS of €1.01.
PE Ratio
BPOST has a trailing twelve months price to earnings ratio of 3.98. Meaning, the purchaser of the share is investing €3.98 for every euro of annual earnings.
Volume
Today’s last reported volume for BPOST is 210257 which is 42.32% below its average volume of 364527.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BPOST’s stock is considered to be overbought (>=80).
Volatility
BPOST’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.53%, a negative 1.39%, and a positive 2.07%.
BPOST’s highest amplitude of average volatility was 2.30% (last week), 3.47% (last month), and 2.07% (last quarter).
More news about BPOST.
6. PCAS (PCA.PA)
6.06% Price Change
PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
CAC 40 ended the session with PCAS rising 6.06% to €7.00 on Thursday, after five consecutive sessions in a row of losses. CAC 40 jumped 0.64% to €7,446.89, after two sequential sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, PCAS has a trailing twelve months EPS of €-3.53.
Moving Average
PCAS’s value is above its 50-day moving average of €6.49 and below its 200-day moving average of €7.13.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PCAS’s stock is considered to be overbought (>=80).
More news about PCAS.
7. FONCIERE EURIS (EURS.PA)
5.26% Price Change
Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties and private equity portfolio. The company was incorporated in 1970 and is based in Paris, France. Foncière Euris SA operates as a subsidiary of Finatis Société Anonyme.
CAC 40 ended the session with FONCIERE EURIS rising 5.26% to €2.00 on Thursday while CAC 40 jumped 0.64% to €7,446.89.
Earnings Per Share
As for profitability, FONCIERE EURIS has a trailing twelve months EPS of €-11.46.
Volatility
FONCIERE EURIS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.43%, a negative 2.19%, and a positive 6.48%.
FONCIERE EURIS’s highest amplitude of average volatility was 8.37% (last week), 6.54% (last month), and 6.48% (last quarter).
More news about FONCIERE EURIS.
8. CRCAM ATL.VEND.CCI (CRAV.PA)
4.77% Price Change
Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée provides banking products and services in France. It offers accounts and card services; real estate loan and consumer credit products; and life insurance products. The company provides real estate investment, and stock exchange and financial investment services, as well as retirement saving solutions. It serves individuals, private banks, businesses, professionals, farmers, public community and social housing, and associations. The company was incorporated in 2001 and is headquartered in Nantes, France. Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée is a subsidiary of Crédit Agricole S.A.
CAC 40 ended the session with CRCAM ATL.VEND.CCI jumping 4.77% to €87.48 on Thursday, after two successive sessions in a row of gains. CAC 40 rose 0.64% to €7,446.89, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, CRCAM ATL.VEND.CCI has a trailing twelve months EPS of €17.38.
PE Ratio
CRCAM ATL.VEND.CCI has a trailing twelve months price to earnings ratio of 5.03. Meaning, the purchaser of the share is investing €5.03 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.74%.
Moving Average
CRCAM ATL.VEND.CCI’s worth is way above its 50-day moving average of €79.52 and way above its 200-day moving average of €76.43.
Volume
Today’s last reported volume for CRCAM ATL.VEND.CCI is 586 which is 39.19% above its average volume of 421.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CRCAM ATL.VEND.CCI’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.5%, now sitting on 473.48M for the twelve trailing months.
More news about CRCAM ATL.VEND.CCI.
9. INVENTIVA (IVA.PA)
4.74% Price Change
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
CAC 40 ended the session with INVENTIVA jumping 4.74% to €2.32 on Thursday, after three consecutive sessions in a row of losses. CAC 40 rose 0.64% to €7,446.89, after two successive sessions in a row of losses, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, INVENTIVA has a trailing twelve months EPS of €-1.27.
Volume
Today’s last reported volume for INVENTIVA is 26785 which is 63.35% below its average volume of 73088.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INVENTIVA’s stock is considered to be overbought (>=80).
Volatility
INVENTIVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.82%, a negative 0.58%, and a positive 2.95%.
INVENTIVA’s highest amplitude of average volatility was 2.14% (last week), 3.57% (last month), and 2.95% (last quarter).
More news about INVENTIVA.
10. GALAPAGOS (GLPG.AS)
4.26% Price Change
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of?various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG3667 that has completed Phase 1b trial; and GLPG5101 and GLPG5201, CD19 CAR-T product candidate manufactures at point-of-care, that is in Phase I/II in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
AEX-Index ended the session with GALAPAGOS rising 4.26% to €39.68 on Thursday while AEX-Index rose 0.92% to €765.28.
Earnings Per Share
As for profitability, GALAPAGOS has a trailing twelve months EPS of €-2.82.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.43%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
GALAPAGOS’s EBITDA is 8.45.
Volatility
GALAPAGOS’s last week, last month’s, and last quarter’s current intraday variation average was 0.13%, 0.55%, and 1.34%.
GALAPAGOS’s highest amplitude of average volatility was 1.27% (last week), 1.29% (last month), and 1.34% (last quarter).
Yearly Top and Bottom Value
GALAPAGOS’s stock is valued at €39.68 at 22:40 EST, way under its 52-week high of €59.54 and way above its 52-week low of €33.28.
More news about GALAPAGOS.
Losers Today
1. NEW SOURCES ENERGY (NSE.AS)
-18.99% Price Change
New Sources Energy N.V. develops, operates, exploits, and invests in projects that generates electricity using renewable energy sources. The company was formerly known as Management Share NV and changed its name to New Sources Energy N.V. in July 2011. New Sources Energy N.V. is headquartered in Amersfoort, the Netherlands.
AEX-Index ended the session with NEW SOURCES ENERGY sliding 18.99% to €0.03 on Thursday, following the last session’s upward trend. AEX-Index rose 0.92% to €765.28, after five consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
More news about NEW SOURCES ENERGY.
2. ATENOR (ATEB.BR)
-15.09% Price Change
Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, and Romania. It develops real estate projects, such as offices and residential buildings. The company was founded in 1910 and is headquartered in La Hulpe, Belgium.
BEL 20 ended the session with ATENOR dropping 15.09% to €31.50 on Thursday while BEL 20 rose 0.97% to €3,717.30.
Earnings Per Share
As for profitability, ATENOR has a trailing twelve months EPS of €-0.12.
Volume
Today’s last reported volume for ATENOR is 12782 which is 554.48% above its average volume of 1953.
More news about ATENOR.
3. CNOVA (CNV.PA)
-9.31% Price Change
Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.
CAC 40 ended the session with CNOVA sliding 9.31% to €3.80 on Thursday while CAC 40 rose 0.64% to €7,446.89.
Earnings Per Share
As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.
Moving Average
CNOVA’s worth is under its 50-day moving average of €3.87 and higher than its 200-day moving average of €3.60.
Revenue Growth
Year-on-year quarterly revenue growth declined by 29%, now sitting on 1.7B for the twelve trailing months.
Volume
Today’s last reported volume for CNOVA is 3340 which is 78.32% above its average volume of 1873.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CNOVA’s stock is considered to be oversold (<=20).
More news about CNOVA.
4. LAVIDE HOLDING (LVIDE.AS)
-9.24% Price Change
Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.
AEX-Index ended the session with LAVIDE HOLDING dropping 9.24% to €0.22 on Thursday while AEX-Index jumped 0.92% to €765.28.
Earnings Per Share
As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.03.
More news about LAVIDE HOLDING.
5. FUT.CLUBE PORTO (FCP.LS)
-7.96% Price Change
Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.
PSI ended the session with FUT.CLUBE PORTO sliding 7.96% to €1.04 on Thursday while PSI fell 0.55% to €6,056.56.
Earnings Per Share
As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €1.04.
PE Ratio
FUT.CLUBE PORTO has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Moving Average
FUT.CLUBE PORTO’s worth is higher than its 50-day moving average of €1.00 and way above its 200-day moving average of €0.90.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.5%, now sitting on 143.78M for the twelve trailing months.
Volatility
FUT.CLUBE PORTO’s last week, last month’s, and last quarter’s current intraday variation average was 3.61%, 0.64%, and 5.40%.
FUT.CLUBE PORTO’s highest amplitude of average volatility was 8.89% (last week), 6.20% (last month), and 5.40% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FUT.CLUBE PORTO’s stock is considered to be oversold (<=20).
More news about FUT.CLUBE PORTO.
6. NANOBIOTIX (NANO.PA)
-6.51% Price Change
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
CAC 40 ended the session with NANOBIOTIX sliding 6.51% to €4.53 on Thursday while CAC 40 rose 0.64% to €7,446.89.
Earnings Per Share
As for profitability, NANOBIOTIX has a trailing twelve months EPS of €-1.72.
Yearly Top and Bottom Value
NANOBIOTIX’s stock is valued at €4.53 at 22:40 EST, way under its 52-week high of €7.10 and way higher than its 52-week low of €1.61.
Volume
Today’s last reported volume for NANOBIOTIX is 197528 which is 17.53% below its average volume of 239525.
More news about NANOBIOTIX.
7. NHOA (NHOA.PA)
-5.79% Price Change
NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.
CAC 40 ended the session with NHOA sliding 5.79% to €3.58 on Thursday while CAC 40 jumped 0.64% to €7,446.89.
Earnings Per Share
As for profitability, NHOA has a trailing twelve months EPS of €-1.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.43%.
More news about NHOA.
8. HYLORIS (HYL.BR)
-4.2% Price Change
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health and other major therapeutic areas. It offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. The company provides Maxigesic IV, a combination of paracetamol and ibuprofen used for post-operative non-opioid pain management; Tranexamic acid RTU, an antifibrinolytic drug for the formation of blood clots; Miconazole/Domiphen Bromide, a topical synergistic combination treatment for Recurrent Vulvovaginal Candidiasis; AlenuraTM, a first-line drug treatment for acute pain in interstitial cystitis/bladder pain syndrome; and Plecoid Agent IV for the treatment of acute myeloid leukemia and small cell lung cancer. It also offers Atomoxetine, an oral liquid for the treatment of patients with attention deficit hyperactivity disorder; HY-029, a liquid formulation of an antiviral drug to treat viral infections; HY-083, a nasal spray for the treatment of idiopathic rhinitis; and HY-088, an oral liquid that treats hypophosphatemia. The company was incorporated in 2012 and is headquartered in Liège, Belgium.
BEL 20 ended the session with HYLORIS dropping 4.2% to €11.40 on Thursday while BEL 20 jumped 0.97% to €3,717.30.
Earnings Per Share
As for profitability, HYLORIS has a trailing twelve months EPS of €-0.39.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.89%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 15.1%, now sitting on 2.95M for the twelve trailing months.
Volatility
HYLORIS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.65%, a negative 0.81%, and a positive 1.51%.
HYLORIS’s highest amplitude of average volatility was 1.65% (last week), 1.47% (last month), and 1.51% (last quarter).
More news about HYLORIS.
9. BIOSENIC (BIOS.BR)
-4% Price Change
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with BIOSENIC falling 4% to €0.12 on Thursday while BEL 20 jumped 0.97% to €3,717.30.
Earnings Per Share
As for profitability, BIOSENIC has a trailing twelve months EPS of €-0.02.
Volatility
BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.42%, a negative 0.13%, and a positive 4.52%.
BIOSENIC’s highest amplitude of average volatility was 3.64% (last week), 5.04% (last month), and 4.52% (last quarter).
Volume
Today’s last reported volume for BIOSENIC is 2522 which is 98.88% below its average volume of 226170.
More news about BIOSENIC.
10. ABIONYX PHARMA (ABNX.PA)
-3.78% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA dropping 3.78% to €1.78 on Thursday, following the last session’s upward trend. CAC 40 rose 0.64% to €7,446.89, after two sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.7%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9640.7%, now sitting on 3.28M for the twelve trailing months.
Volume
Today’s last reported volume for ABIONYX PHARMA is 55244 which is 54.77% below its average volume of 122146.
More news about ABIONYX PHARMA.
Stay up to date with our winners and losers daily report
